Avanos Medical Inc
NYSE:AVNS
Avanos Medical Inc
NYSE:AVNS
Price:
24.62
USD
-0.16%
Market Closed
Market Cap:
$1.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Avanos Medical Inc
NYSE:AVNS
|
US |
|
Creema Ltd
TSE:4017
|
JP |
|
PJT Partners Inc
NYSE:PJT
|
US |
|
M
|
Momentum Biofuels Inc
OTC:VHLD
|
US |
|
REC Limited
NSE:RECLTD
|
IN |
Income Statement
Earnings Waterfall
Avanos Medical Inc
Avanos Medical Inc
Income Statement
Avanos Medical Inc
Avanos Medical Inc
Currency: USD
| Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
6
|
14
|
23
|
31
|
33
|
33
|
32
|
33
|
33
|
32
|
32
|
32
|
32
|
33
|
35
|
31
|
26
|
21
|
15
|
14
|
15
|
16
|
16
|
17
|
16
|
12
|
9
|
5
|
3
|
4
|
6
|
8
|
9
|
11
|
12
|
14
|
15
|
15
|
14
|
13
|
12
|
11
|
10
|
9
|
8
|
|
| Revenue |
1 678
N/A
|
1 677
0%
|
1 675
0%
|
1 664
-1%
|
1 672
+0%
|
1 656
-1%
|
1 631
-1%
|
1 612
-1%
|
509
-68%
|
500
-2%
|
510
+2%
|
518
+2%
|
566
+9%
|
327
-42%
|
76
-77%
|
(171)
N/A
|
612
N/A
|
622
+2%
|
634
+2%
|
649
+2%
|
652
+1%
|
660
+1%
|
671
+2%
|
678
+1%
|
698
+3%
|
714
+2%
|
705
-1%
|
720
+2%
|
715
-1%
|
715
+0%
|
738
+3%
|
736
0%
|
745
+1%
|
723
-3%
|
708
-2%
|
696
-2%
|
820
+18%
|
720
-12%
|
719
0%
|
718
0%
|
673
-6%
|
680
+1%
|
682
+0%
|
682
0%
|
688
+1%
|
689
+0%
|
693
+0%
|
700
+1%
|
701
+0%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(1 065)
|
(1 052)
|
(1 098)
|
(1 117)
|
(1 124)
|
(1 130)
|
(1 076)
|
(1 058)
|
(251)
|
(237)
|
(242)
|
(243)
|
(269)
|
(85)
|
110
|
300
|
(275)
|
(276)
|
(277)
|
(268)
|
(261)
|
(262)
|
(269)
|
(285)
|
(295)
|
(308)
|
(312)
|
(326)
|
(342)
|
(353)
|
(376)
|
(380)
|
(380)
|
(361)
|
(329)
|
(308)
|
(370)
|
(310)
|
(312)
|
(316)
|
(294)
|
(297)
|
(301)
|
(304)
|
(307)
|
(313)
|
(320)
|
(334)
|
(347)
|
|
| Gross Profit |
612
N/A
|
626
+2%
|
577
-8%
|
547
-5%
|
549
+0%
|
526
-4%
|
556
+6%
|
555
0%
|
258
-54%
|
262
+2%
|
268
+2%
|
275
+3%
|
297
+8%
|
242
-19%
|
186
-23%
|
129
-31%
|
337
+161%
|
347
+3%
|
357
+3%
|
380
+7%
|
391
+3%
|
399
+2%
|
403
+1%
|
393
-2%
|
402
+2%
|
406
+1%
|
393
-3%
|
394
+0%
|
373
-5%
|
363
-3%
|
362
0%
|
356
-1%
|
364
+2%
|
363
0%
|
378
+4%
|
388
+3%
|
450
+16%
|
410
-9%
|
406
-1%
|
402
-1%
|
380
-5%
|
383
+1%
|
381
-1%
|
378
-1%
|
381
+1%
|
376
-1%
|
373
-1%
|
366
-2%
|
354
-3%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(387)
|
(379)
|
(392)
|
(420)
|
(454)
|
(452)
|
(456)
|
(453)
|
(394)
|
(406)
|
(416)
|
59
|
(404)
|
(400)
|
(368)
|
(339)
|
(380)
|
(365)
|
(355)
|
(356)
|
(359)
|
(387)
|
(410)
|
(426)
|
(440)
|
(436)
|
(416)
|
(399)
|
(419)
|
(422)
|
(426)
|
(417)
|
(348)
|
(336)
|
(333)
|
(334)
|
(374)
|
(364)
|
(373)
|
(380)
|
(372)
|
(367)
|
(354)
|
(339)
|
(337)
|
(765)
|
(327)
|
(335)
|
(337)
|
|
| Selling, General & Administrative |
(351)
|
(344)
|
(354)
|
(383)
|
(425)
|
(436)
|
(441)
|
(427)
|
(350)
|
(345)
|
(347)
|
(351)
|
(346)
|
(338)
|
(311)
|
(290)
|
(322)
|
(320)
|
(315)
|
(318)
|
(325)
|
(346)
|
(360)
|
(365)
|
(381)
|
(368)
|
(355)
|
(351)
|
(333)
|
(315)
|
(315)
|
(307)
|
(300)
|
(311)
|
(317)
|
(320)
|
(340)
|
(330)
|
(340)
|
(340)
|
(332)
|
(328)
|
(314)
|
(309)
|
(314)
|
(307)
|
(312)
|
(316)
|
(314)
|
|
| Research & Development |
(38)
|
(39)
|
(40)
|
(40)
|
(34)
|
(31)
|
(28)
|
(30)
|
(28)
|
(30)
|
(34)
|
(34)
|
(38)
|
(37)
|
(37)
|
(35)
|
(38)
|
(41)
|
(42)
|
(43)
|
(42)
|
(42)
|
(41)
|
(40)
|
(38)
|
(37)
|
(35)
|
(34)
|
(35)
|
(34)
|
(34)
|
(34)
|
(32)
|
(31)
|
(31)
|
(30)
|
(31)
|
(30)
|
(29)
|
(28)
|
(27)
|
(27)
|
(26)
|
(27)
|
(26)
|
(25)
|
(24)
|
(23)
|
(23)
|
|
| Other Operating Expenses |
2
|
4
|
2
|
3
|
4
|
15
|
13
|
3
|
(16)
|
(30)
|
(35)
|
444
|
(20)
|
(25)
|
(20)
|
(14)
|
(20)
|
(4)
|
3
|
5
|
7
|
1
|
(10)
|
(21)
|
(21)
|
(31)
|
(26)
|
(14)
|
(52)
|
(73)
|
(78)
|
(76)
|
(15)
|
7
|
15
|
16
|
(4)
|
(5)
|
(4)
|
(11)
|
(13)
|
(12)
|
(14)
|
(4)
|
4
|
(433)
|
8
|
5
|
0
|
|
| Operating Income |
225
N/A
|
247
+9%
|
185
-25%
|
128
-31%
|
94
-26%
|
74
-22%
|
100
+36%
|
101
+1%
|
(136)
N/A
|
(144)
-6%
|
(148)
-3%
|
334
N/A
|
(107)
N/A
|
(158)
-47%
|
(182)
-15%
|
(210)
-15%
|
(43)
+79%
|
(19)
+57%
|
2
N/A
|
24
+1 256%
|
32
+30%
|
12
-63%
|
(8)
N/A
|
(33)
-344%
|
(38)
-14%
|
(31)
+20%
|
(23)
+26%
|
(5)
+80%
|
(46)
-924%
|
(59)
-28%
|
(65)
-9%
|
(61)
+6%
|
17
N/A
|
27
+61%
|
45
+68%
|
55
+21%
|
76
+39%
|
46
-39%
|
33
-28%
|
22
-34%
|
8
-66%
|
16
+119%
|
27
+63%
|
39
+44%
|
45
+16%
|
(390)
N/A
|
45
N/A
|
31
-30%
|
17
-46%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
3
|
3
|
3
|
4
|
(3)
|
(12)
|
(22)
|
(31)
|
(33)
|
(32)
|
(32)
|
(32)
|
(32)
|
(32)
|
(31)
|
(30)
|
(29)
|
(30)
|
(30)
|
(25)
|
(19)
|
(12)
|
(6)
|
(6)
|
(8)
|
(11)
|
(13)
|
(15)
|
(14)
|
(12)
|
(8)
|
(5)
|
(3)
|
(4)
|
(5)
|
(7)
|
(8)
|
(11)
|
(11)
|
(12)
|
(12)
|
(12)
|
(9)
|
(7)
|
(7)
|
(5)
|
(7)
|
(5)
|
(5)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(476)
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
(9)
|
0
|
(14)
|
(13)
|
(19)
|
(31)
|
(29)
|
(28)
|
(28)
|
(18)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
(10)
|
(11)
|
(11)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(2)
|
(4)
|
(5)
|
(441)
|
0
|
(515)
|
(514)
|
(79)
|
|
| Pre-Tax Income |
228
N/A
|
250
+10%
|
189
-24%
|
132
-30%
|
91
-31%
|
61
-33%
|
78
+28%
|
(405)
N/A
|
(169)
+58%
|
(176)
-4%
|
(180)
-2%
|
302
N/A
|
(139)
N/A
|
(189)
-36%
|
(218)
-15%
|
(249)
-14%
|
(72)
+71%
|
(62)
+14%
|
(42)
+33%
|
(19)
+55%
|
(18)
+4%
|
(29)
-61%
|
(42)
-42%
|
(67)
-61%
|
(64)
+4%
|
(41)
+36%
|
(36)
+13%
|
(20)
+45%
|
(61)
-209%
|
(71)
-17%
|
(73)
-3%
|
(66)
+10%
|
6
N/A
|
14
+136%
|
30
+115%
|
37
+24%
|
65
+78%
|
33
-50%
|
20
-39%
|
7
-64%
|
(8)
N/A
|
3
N/A
|
14
+419%
|
26
+86%
|
(403)
N/A
|
(395)
+2%
|
(477)
-21%
|
(488)
-2%
|
(66)
+86%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(73)
|
(82)
|
(64)
|
(62)
|
(64)
|
(54)
|
(58)
|
(38)
|
67
|
67
|
70
|
68
|
56
|
77
|
88
|
99
|
30
|
24
|
16
|
8
|
6
|
8
|
11
|
21
|
18
|
19
|
19
|
34
|
33
|
32
|
75
|
14
|
(1)
|
(5)
|
(54)
|
(15)
|
(15)
|
(8)
|
(4)
|
(11)
|
(2)
|
(4)
|
(7)
|
(4)
|
17
|
15
|
16
|
19
|
(7)
|
|
| Income from Continuing Operations |
155
|
168
|
125
|
69
|
27
|
7
|
20
|
(443)
|
(101)
|
(109)
|
(110)
|
369
|
(83)
|
(112)
|
(130)
|
(150)
|
(42)
|
(39)
|
(26)
|
(11)
|
(12)
|
(21)
|
(31)
|
(46)
|
(46)
|
(22)
|
(17)
|
14
|
(27)
|
(39)
|
2
|
(52)
|
5
|
9
|
(24)
|
22
|
51
|
25
|
16
|
(4)
|
(10)
|
(2)
|
7
|
22
|
(386)
|
(380)
|
(461)
|
(469)
|
(73)
|
|
| Net Income (Common) |
155
N/A
|
168
+8%
|
125
-26%
|
69
-44%
|
27
-61%
|
7
-73%
|
20
+169%
|
(443)
N/A
|
(426)
+4%
|
(434)
-2%
|
(435)
0%
|
44
N/A
|
40
-10%
|
38
-4%
|
49
+28%
|
57
+15%
|
79
+40%
|
87
+9%
|
105
+21%
|
93
-12%
|
58
-38%
|
17
-70%
|
(26)
N/A
|
(42)
-60%
|
(46)
-9%
|
(22)
+52%
|
(17)
+23%
|
14
N/A
|
(27)
N/A
|
(39)
-42%
|
2
N/A
|
(52)
N/A
|
5
N/A
|
18
+250%
|
(7)
N/A
|
44
N/A
|
51
+16%
|
45
-12%
|
(36)
N/A
|
(55)
-54%
|
(62)
-12%
|
(62)
-1%
|
8
N/A
|
16
+104%
|
(392)
N/A
|
(385)
+2%
|
(463)
-20%
|
(469)
-1%
|
(73)
+84%
|
|
| EPS (Diluted) |
3.32
N/A
|
3.61
+9%
|
2.68
-26%
|
1.49
-44%
|
0.58
-61%
|
0.15
-74%
|
0.42
+180%
|
-9.52
N/A
|
-9.14
+4%
|
-9.26
-1%
|
-9.28
0%
|
0.93
N/A
|
0.85
-9%
|
0.82
-4%
|
1.04
+27%
|
1.2
+15%
|
1.69
+41%
|
1.84
+9%
|
2.17
+18%
|
1.9
-12%
|
1.21
-36%
|
0.35
-71%
|
-0.55
N/A
|
-0.88
-60%
|
-0.96
-9%
|
-0.46
+52%
|
-0.35
+24%
|
0.29
N/A
|
-0.57
N/A
|
-0.81
-42%
|
0.03
N/A
|
-1.1
N/A
|
0.11
N/A
|
0.38
+245%
|
-0.15
N/A
|
0.92
N/A
|
1.07
+16%
|
0.95
-11%
|
-0.76
N/A
|
-1.18
-55%
|
-1.32
-12%
|
-1.34
-2%
|
0.15
N/A
|
0.33
+120%
|
-8.52
N/A
|
-8.21
+4%
|
-10.02
-22%
|
-10.1
-1%
|
-1.57
+84%
|
|
Switch to:
Switch to:
See Also
Discover More
